No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
SMMT241220P18000
- 0.35
- +0.15+75.00%
15min DelayClose Dec 20 16:00 ET
0.35High0.02Low
0.35Open0.20Pre Close66 Volume192 Open Interest18.00Strike Price780.00Turnover8731.65%IV1.23%PremiumDec 20, 2024Expiry Date0.13Intrinsic Value100Multiplier-1DDays to Expiry0.22Extrinsic Value100Contract SizeAmericanOptions Type-0.5484Delta0.5379Gamma51.06Leverage Ratio-1845.4897Theta0.0000Rho-28.00Eff Leverage0.0000Vega
Intraday
- 5D
- Daily
News
Why Did Summit Therapeutics Inc. (SMMT) Jump Yesterday?
Where Will Summit Therapeutics Be in 5 Years?
Summit Therapeutics Shares Are Trading Higher. The Stock May Be Moving in Sympathy With Neurocrine Biosciences Which Received FDA Approval for CRESNESSITY.
Watching Summit Therapeutics; Traders Circulate Newsletter Mention
How Is The Market Feeling About Summit Therapeutics?
Summit Therapeutics Initiated at Overweight by Wells Fargo